Drug Effective for Temporary Sleep Disruptions San Francisco CA

By simultaneously improving sleep latency and sleep maintenance with a shift in circadian rhythms, tasimelteon has the potential for the treatment of patients with transient insomnia associated with circadian rhythm sleep disorders.

Local Companies

Bay Area Psychological Testing
(415) 296-8081
870 Market St Suite 1181
San Francisco, CA
201 Sanchez Associates
(415) 255-8591
201 Sanchez
San Francisco, CA
Simla Somturk, Health Counselor
(415) 595-5775
1504 Lyon St.
San Francisco, CA
Krista Bray, Posture Alignment Specialist
(415) 202-3229
3150 18th St., Ste. 463
San Francisco, CA
Home Within
(415) 621-1749
2500 18th
San Francisco, CA
Catholic Healthcare West
(415) 438-5500
185 Berry St., Ste. 300
San Francisco, CA
Ace Tricia Mft
(415) 281-8464
600 Folsom St
San Francisco, CA
A Center For Couseling &
(415) 931-4888
2084 Union
San Francisco, CA
Ilene Wolf M.A MFT
415.263.6744
2918 Webster St
San Francisco, CA
Abrinko Paul MD
(415) 561-6793
10 Funston
San Francisco, CA

The experimental drug tasimelteon helps treat temporary insomnia caused by jet lag or night shifts, according to the results of two new clinical trials.

The phase II study included 39 people randomly assigned to receive either 10 milligrams, 20 mg, 50 mg or 100 mg of tasimelteon, or a placebo. They were monitored for seven nights -- three at baseline, three after a five-hour advance of sleep-wake schedule with treatment before sleep, and one night after treatment.

The phase III trial included 411 people who had transient insomnia induced in a sleep clinic by a five-hour advance of their sleep-wake cycle. They received either 20 mg, 50 mg, or 100 mg of tasimelteon, or a placebo, 30 minutes before bedtime.

The patients in the trials were monitored to determine their sleep efficiency (amount of actual sleep during their time in bed) and sleep latency (time it took them to fall asleep). Compared to placebo, tasimelteon (a melatonin analogue) improved sleep efficiency and reduced sleep latency, according to the researchers. They also found that patients taking tasimelteon showed an earlier shift in plasma melatonin rhythm.

The findings were published online and in an upcoming print issue of the The Lancet.

"The development of melatonin analogues, which specifically target melatonin receptors, will also help us to understand more about the role of the hormone melatonin in the regulation of sleep," the American and Australian researchers said in a journal news release.

"By simultaneously improving sleep latency and sleep maintenance with a shift in circadian rhythms, tasimelteon has the potential for the treatment of patients with transient insomnia associated with circadian rhythm sleep disorders, including people affected by jet leg, or those who work at night, and early-riser workers," the study authors concluded.

More information

The U.S. National Sleep Foundation has more about shift work.

SOURCE: The Lancet, news release, Dec. 1, 2008

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Featured Local Company

Bay Area Psychological Testing

4152968081
870 Market St Suite 1181
San Francisco, CA

Related Local Events
Alternative Press Expo (APE 2009)
Dates: 10/17/2009 - 10/18/2009
Location: Concourse Exhibition Center, San Francisco
San Francisco, CA
View Details

Business Issues Committee Meeting
Dates: 6/26/2009 - 6/26/2009
Location: Fairfield-Suisun Chamber of Commerce
Fairfield, CA
View Details

Executive Board Meeting
Dates: 6/23/2009 - 6/23/2009
Location: Fairfield-Suisun Chamber of Commerce
Fairfield, CA
View Details

Membership Committee Meeting
Dates: 6/18/2009 - 6/18/2009
Location: Fairfield-Suisun Chamber of Commerce
Fairfield, CA
View Details

Suisun City Business Group Meeting
Dates: 6/18/2009 - 6/18/2009
Location: Suisun City Council Chambers
Suisun, CA
View Details